SignalFDA/Bio

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

Positive Phase 2 data for RSV/hMPV/PIV3 vaccine candidates in older adults.

What changed

Positive Phase 2 data for RSV/hMPV/PIV3 vaccine candidates in older adults.

Why it matters

Positive Phase 2 data for RSV/hMPV/PIV3 vaccine candidates in older adults. — impact context not separately stored; see What changed.

Sources